Stefano Pallanti, MD, PhD

Article

Antibiotics for PANDAS?

May 3, 2018

Antibiotics have been extensively used by clinicians to treat patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome. In this review, the authors...

Stefano Pallanti, Elisabetta Burchi

Original Research

Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

August 10, 2010

Eric Hollander, Lorrin M. Koran, Stefano Pallanti, et al

Academic Highlights

Obsessive-Compulsive Disorder: Strategies for Optimal Treatment

October 31, 2008

Eric Hollander, Lorrin M. Koran, Stefano Pallanti, et al

Article

A Qualitative Analysis of Nonresponse: Management of Treatment-Refractory Obsessive-Compulsive Disorder

December 15, 2004

Eric Hollander, Wayne K. Goodman, Stefano Pallanti

Original Research

Response Acceleration With Mirtazapine Augmentation of Citalopram in Obsessive-Compulsive Disorder Patients Without Comorbid Depression: A Pilot Study

October 15, 2004

Stefano Pallanti, Leonardo Quercioli, Matteo Bruscoli

Original Research

Nefazodone Treatment of Pathological Gambling: A Prospective Open-Label Controlled Trial

November 1, 2002

Eric Hollander, Stefano Pallanti, Erica Sood, et al

Original Research

Citalopram Intravenous Infusion in Resistant Obsessive-Compulsive Disorder: An Open Trial

September 23, 2002

Lorrin M. Koran, Stefano Pallanti, Leonardo Quercioli

Original Research

Lithium and Valproate Treatment of Pathological Gambling: A Randomized Single-Blind Study

July 16, 2002

Eric Hollander, Stefano Pallanti, Leonardo Quercioli, et al

Article

Refractory Obsessive-Compulsive Disorder: State-of-the-Art Treatment

June 1, 2002

Eric Hollander, Lorrin M. Koran, Sanjaya Saxena, et al

Original Research

The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation

December 31, 1999

Stefano Pallanti, Leonardo Quercioli, Alessandro Rossi, et al

Antibiotics for PANDAS?

Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder: Strategies for Optimal Treatment

A Qualitative Analysis of Nonresponse: Management of Treatment-Refractory Obsessive-Compulsive Disorder

Response Acceleration With Mirtazapine Augmentation of Citalopram in Obsessive-Compulsive Disorder Patients Without Comorbid Depression: A Pilot Study

Nefazodone Treatment of Pathological Gambling: A Prospective Open-Label Controlled Trial

Citalopram Intravenous Infusion in Resistant Obsessive-Compulsive Disorder: An Open Trial

Lithium and Valproate Treatment of Pathological Gambling: A Randomized Single-Blind Study

Refractory Obsessive-Compulsive Disorder: State-of-the-Art Treatment

The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation

ELSEWHERE:

FOLLOW US:

Stefano Pallanti, MD, PhD

Antibiotics for PANDAS?

Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder: Strategies for Optimal Treatment

A Qualitative Analysis of Nonresponse: Management of Treatment-Refractory Obsessive-Compulsive Disorder

Response Acceleration With Mirtazapine Augmentation of Citalopram in Obsessive-Compulsive Disorder Patients Without Comorbid Depression: A Pilot Study

Nefazodone Treatment of Pathological Gambling: A Prospective Open-Label Controlled Trial

Citalopram Intravenous Infusion in Resistant Obsessive-Compulsive Disorder: An Open Trial

Lithium and Valproate Treatment of Pathological Gambling: A Randomized Single-Blind Study

Refractory Obsessive-Compulsive Disorder: State-of-the-Art Treatment

The Emergence of Social Phobia During Clozapine Treatment and Its Response to Fluoxetine Augmentation

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles